MedTrace Logo

Study Evaluating the Safety of KetoNaph Ophthalmic Solution in Healthy Volunteers

NCT01159015 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 534

Last updated 2020-10-05

Study results available
· View outcomes & findings →

Summary

This study is being conducted to evaluate the safety of KetoNaph ophthalmic solution in healthy adult subjects and in pediatric subjects with a history or family history of ocular allergy.

Conditions

  • Allergic Conjunctivitis

Interventions

DRUG

KetoNaph

Ophthalmic Solution administered BID for 6 weeks

DRUG

Vehicle

Vehicle of KetoNaph ophthalmic solution administered bid for six weeks

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Tuyen Ong, MD · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2010-09-30
Completion
2010-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01159015 on ClinicalTrials.gov